DYADIC INTERNATIONAL INC Total Assets
DYADIC INTERNATIONAL INC (DYAI) had Total Assets of $6.54 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-12
- 2026-06-30: Assets $6.54M.
- 2026-03-31: Assets $7.81M.
- 2025-12-31: Assets $9.95M.
- 2025-09-30: Assets $11.67M.
| Period end | Assets |
|---|---|
| 2026-06-30 | $6.54M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $7.81M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $9.95M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $11.67M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $8.14M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $7.89M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $9.93M 10-K · filed 2026-03-25 |
| 2024-09-30 | $10.81M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $10.63M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $12.68M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $8.22M 10-K · filed 2025-03-26 |
| 2023-09-30 | $9.26M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $11.07M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $12.81M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $13.71M 10-K · filed 2024-03-28 |
| 2022-09-30 | $15.22M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $17.22M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $18.53B 10-Q · filed 2022-05-12 |
| 2021-12-31 | $21.30M 10-K · filed 2023-03-29 |
| 2021-09-30 | $23.86M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $26.45M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $28.28M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $30.07M 10-K · filed 2022-03-29 |
| 2020-09-30 | $31.75M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $33.73M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $35.39M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $37.45M 10-K · filed 2021-03-30 |
| 2019-09-30 | $38.52M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $40.07M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $41.86M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $43.30M 10-K · filed 2020-03-30 |
| 2017-12-31 | $50.74M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |